Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Income Statement
Earnings Waterfall
Arrowhead Pharmaceuticals Inc
Revenue
|
181.7m
USD
|
Operating Expenses
|
-481.1m
USD
|
Operating Income
|
-299.4m
USD
|
Other Expenses
|
2.6m
USD
|
Net Income
|
-296.7m
USD
|
Income Statement
Arrowhead Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+50%
|
0
+33%
|
0
-75%
|
0
N/A
|
0
N/A
|
0
N/A
|
4
+2 100%
|
13
+205%
|
23
+69%
|
31
+38%
|
31
-3%
|
22
-27%
|
14
-39%
|
16
+18%
|
47
+194%
|
95
+100%
|
137
+44%
|
169
+23%
|
164
-3%
|
139
-15%
|
124
-11%
|
88
-29%
|
80
-9%
|
89
+12%
|
108
+21%
|
138
+29%
|
144
+4%
|
263
+82%
|
250
-5%
|
243
-3%
|
278
+14%
|
273
-2%
|
256
-6%
|
241
-6%
|
182
-24%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(26)
|
(33)
|
(39)
|
(51)
|
(72)
|
(90)
|
(94)
|
(96)
|
(91)
|
(82)
|
(85)
|
(80)
|
(82)
|
(76)
|
(71)
|
(68)
|
(67)
|
(67)
|
(69)
|
(72)
|
(78)
|
(89)
|
(96)
|
(108)
|
(118)
|
(138)
|
(157)
|
(181)
|
(192)
|
(208)
|
(242)
|
(287)
|
(333)
|
(382)
|
(410)
|
(422)
|
(436)
|
(424)
|
(437)
|
(446)
|
(481)
|
|
Selling, General & Administrative |
(9)
|
(13)
|
(17)
|
(19)
|
(28)
|
(30)
|
(32)
|
(23)
|
(36)
|
(39)
|
(40)
|
(27)
|
(41)
|
(38)
|
(36)
|
(20)
|
(31)
|
(28)
|
(26)
|
(19)
|
(21)
|
(22)
|
(23)
|
(27)
|
(31)
|
(42)
|
(48)
|
(52)
|
(50)
|
(50)
|
(57)
|
(80)
|
(96)
|
(114)
|
(129)
|
(130)
|
(121)
|
(112)
|
(106)
|
(101)
|
(105)
|
|
Research & Development |
(13)
|
(15)
|
(19)
|
(28)
|
(38)
|
(54)
|
(55)
|
(69)
|
(50)
|
(38)
|
(40)
|
(55)
|
(41)
|
(38)
|
(35)
|
(43)
|
(31)
|
(36)
|
(41)
|
(53)
|
(58)
|
(67)
|
(74)
|
(81)
|
(86)
|
(93)
|
(105)
|
(124)
|
(136)
|
(151)
|
(178)
|
(199)
|
(228)
|
(259)
|
(271)
|
(281)
|
(304)
|
(301)
|
(319)
|
(332)
|
(362)
|
|
Depreciation & Amortization |
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(4)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(13)
|
(14)
|
|
Other Operating Expenses |
(1)
|
(3)
|
0
|
(2)
|
(5)
|
(5)
|
(5)
|
(2)
|
(2)
|
0
|
(2)
|
6
|
4
|
4
|
4
|
0
|
0
|
(4)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(26)
N/A
|
(33)
-28%
|
(39)
-19%
|
(51)
-31%
|
(71)
-40%
|
(90)
-26%
|
(93)
-4%
|
(96)
-3%
|
(90)
+6%
|
(82)
+9%
|
(85)
-4%
|
(80)
+6%
|
(77)
+3%
|
(62)
+20%
|
(49)
+22%
|
(37)
+24%
|
(36)
+3%
|
(45)
-25%
|
(55)
-23%
|
(56)
-2%
|
(31)
+44%
|
6
N/A
|
40
+595%
|
61
+52%
|
45
-26%
|
1
-98%
|
(33)
N/A
|
(93)
-179%
|
(112)
-20%
|
(118)
-5%
|
(134)
-14%
|
(149)
-11%
|
(188)
-26%
|
(119)
+37%
|
(160)
-35%
|
(179)
-12%
|
(157)
+12%
|
(151)
+4%
|
(180)
-20%
|
(205)
-14%
|
(299)
-46%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(10)
|
(12)
|
(11)
|
(6)
|
1
|
4
|
3
|
4
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
2
|
2
|
4
|
5
|
7
|
8
|
9
|
9
|
9
|
9
|
8
|
7
|
6
|
5
|
5
|
5
|
5
|
4
|
2
|
(0)
|
(3)
|
(5)
|
|
Non-Reccuring Items |
(1)
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
1
|
1
|
1
|
2
|
0
|
2
|
1
|
1
|
2
|
0
|
1
|
2
|
1
|
|
Pre-Tax Income |
(38)
N/A
|
(45)
-19%
|
(50)
-12%
|
(59)
-17%
|
(71)
-20%
|
(85)
-21%
|
(90)
-5%
|
(92)
-3%
|
(89)
+4%
|
(81)
+9%
|
(84)
-4%
|
(82)
+3%
|
(75)
+9%
|
(60)
+20%
|
(46)
+23%
|
(34)
+25%
|
(35)
-3%
|
(44)
-25%
|
(54)
-23%
|
(54)
N/A
|
(29)
+46%
|
10
N/A
|
45
+378%
|
68
+50%
|
53
-22%
|
10
-82%
|
(24)
N/A
|
(85)
-250%
|
(103)
-21%
|
(110)
-7%
|
(126)
-15%
|
(141)
-12%
|
(183)
-30%
|
(112)
+39%
|
(154)
-38%
|
(173)
-12%
|
(152)
+12%
|
(148)
+2%
|
(180)
-21%
|
(207)
-15%
|
(303)
-47%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(4)
|
(5)
|
(3)
|
1
|
|
Income from Continuing Operations |
(38)
|
(45)
|
(50)
|
(59)
|
(71)
|
(85)
|
(90)
|
(92)
|
(89)
|
(81)
|
(84)
|
(82)
|
(75)
|
(60)
|
(46)
|
(34)
|
(35)
|
(44)
|
(54)
|
(55)
|
(29)
|
10
|
45
|
68
|
53
|
10
|
(24)
|
(85)
|
(103)
|
(110)
|
(126)
|
(141)
|
(183)
|
(112)
|
(154)
|
(177)
|
(155)
|
(152)
|
(184)
|
(209)
|
(303)
|
|
Income to Minority Interest |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
6
|
|
Net Income (Common) |
(37)
N/A
|
(44)
-19%
|
(50)
-12%
|
(59)
-18%
|
(71)
-20%
|
(85)
-21%
|
(90)
-5%
|
(92)
-3%
|
(89)
+4%
|
(81)
+9%
|
(84)
-4%
|
(82)
+3%
|
(75)
+9%
|
(60)
+20%
|
(46)
+23%
|
(34)
+25%
|
(35)
-3%
|
(44)
-25%
|
(54)
-23%
|
(55)
0%
|
(29)
+46%
|
10
N/A
|
45
+378%
|
68
+50%
|
53
-22%
|
10
-82%
|
(24)
N/A
|
(85)
-247%
|
(103)
-21%
|
(110)
-7%
|
(126)
-15%
|
(141)
-12%
|
(183)
-30%
|
(112)
+39%
|
(154)
-38%
|
(176)
-14%
|
(154)
+12%
|
(150)
+3%
|
(181)
-21%
|
(205)
-13%
|
(297)
-45%
|
|
EPS (Diluted) |
-0.87
N/A
|
-1.11
-28%
|
-0.95
+14%
|
-1.25
-32%
|
-1.27
-2%
|
-1.39
-9%
|
-1.5
-8%
|
-1.6
-7%
|
-1.49
+7%
|
-1.36
+9%
|
-1.41
-4%
|
-1.34
+5%
|
-1.04
+22%
|
-0.8
+23%
|
-0.61
+24%
|
-0.47
+23%
|
-0.47
N/A
|
-0.52
-11%
|
-0.62
-19%
|
-0.65
-5%
|
-0.3
+54%
|
0.09
N/A
|
0.46
+411%
|
0.69
+50%
|
0.54
-22%
|
0.1
-81%
|
-0.24
N/A
|
-0.84
-250%
|
-1
-19%
|
-1.06
-6%
|
-1.22
-15%
|
-1.36
-11%
|
-1.76
-29%
|
-1.03
+41%
|
-1.45
-41%
|
-1.67
-15%
|
-1.47
+12%
|
-1.38
+6%
|
-1.71
-24%
|
-1.92
-12%
|
-2.77
-44%
|